Cardiovascular Systems, Inc. (CSI) has signed an exclusive international distribution agreement with OrbusNeich to sell its coronary and peripheral orbital atherectomy systems (OAS) outside the USA and Japan. OrbusNeich manufactures and sells an extensive portfolio of coronary and peripheral products including stents, balloons and microcatheters. The company operates 12 regional sales offices throughout the world and their products are currently sold in over 60 countries.
Scott Ward, chairman, president and chief executive officer of CSI, says: “We are excited to expand our strategic partnership with OrbusNeich, a globally recognised leader offering an extensive portfolio of vascular intervention products. OrbusNeich’s large international sales channel serves Europe, Asia and the Middle East and greatly accelerates our plans to introduce orbital atherectomy technology to international markets. In turn, we will focus our international efforts on physician training and education to support the expanded use of orbital atherectomy.”
David Chien, chairman and chief executive officer of OrbusNeich comments: “Our experienced sales force is eager to extend CSI’s market leadership in peripheral and coronary atherectomy to new international markets. We intend to introduce CSI’s orbital atherectomy systems in multiple countries in Europe and Southeast Asia this calendar year—focusing initially on those countries that recognise US approvals in addition to European markets where CSI has CE Mark approval for its peripheral technology.”
CSI management will provide more details on this distribution agreement on July 31st at its Analyst Day meeting.
In January 2018, CSI announced that it was the exclusive US distributor for OrbusNeich balloon products. Ultimately, CSI will offer a full line of semi-compliant, non-compliant and specialty balloons for both coronary and peripheral vascular procedures. OrbusNeich PCI balloons include the Sapphire II Pro, the first and only 1.0mm coronary balloon available in the USA. Currently, CSI offers both the 1.0–4.0mm Sapphire II Pro and the 2.0–4.0mm Sapphire NC Plus coronary balloons.
In November 2016, CSI announced that Medikit signed an exclusive distribution agreement to sell its coronary and peripheral OAS in Japan.
